Ian Brennan is an Executive Portfolio Strategy Leader at Roche/Genentech, where they guide strategic investments across the drug development pipeline. Previously, they held multiple leadership roles at Genentech, including Global Head of Competitive Intelligence and Oncology Head, Competitive Intelligence, driving analytics to inform patient-centered strategies. Ian's early career included positions as a biochemist at Children's Hospital Boston and as a senior scientist at Amunix, where they led pharmaceutical development projects. They earned a Ph.D. in Biochemistry from Stanford University, following a Bachelor of Arts in Biology from Harvard University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices